Literature DB >> 27699607

To assess the efficacy of vertical muscle surgery for management of hypotropia in monocular elevation deficiency type II.

Shweta Dhiman1,2, Prolima Thacker3, Babita Karothiya3, Yashpal Goel3, Anju Rastogi3, Rupak Chaudhary3.   

Abstract

AIM: To assess the efficacy of vertical muscle surgery for management of hypotropia in monocular elevation deficiency (MED) type II. Knapp's is described as standard procedure for management of MED type II. However, it is not graded and has unpredictable amount of correction. Besides this, there is drift towards overcorrection with time and limitation of movements in extreme adduction and abduction. MED is a vertical misalignment for which vertical muscle surgery is also described but limited literature is available.
METHODS: Thirteen fresh cases of MED type II with hypotropia >20 PD and age >4 years were included in our interventional study. All cases underwent superior rectus resection and inferior rectus recession (vertical R&amp;R) depending upon amount of preoperative deviation. Success was defined as hypotropia <5 PD at 1-year follow-up.
RESULTS: Twelve patients (92.30 %) were aligned to within 5 PD. Six patients (46.15 %) had gain in elevation. Bell's phenomenon was improved in six patients (46.15 %). There was no limitation in down gaze in any patient. None gained stereopsis.
CONCLUSION: Vertical R&amp;R is a good alternative for MED type II with predictable amount of correction especially in patients with higher preoperative deviation. It spares horizontal muscles for correction of any associated horizontal deviation.

Entities:  

Keywords:  MED; Resection and recession (R&R); Strabismus

Mesh:

Year:  2016        PMID: 27699607     DOI: 10.1007/s10792-016-0365-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  15 in total

1.  Management of ipsilateral ptosis with hypotropia.

Authors:  L A Ficker; J R Collin; J P Lee
Journal:  Br J Ophthalmol       Date:  1986-10       Impact factor: 4.638

2.  Congenital double elevator palsy in identical twins.

Authors:  J A Bell; A R Fielder; S Viney
Journal:  J Clin Neuroophthalmol       Date:  1990-03

3.  Effect of full tendon transposition augmented with posterior intermuscular suture for paralytic strabismus.

Authors:  Samin Hong; Yoon-Hee Chang; Sueng-Han Han; Jong Bok Lee
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

4.  The surgical treatment of double-elevator paralysis.

Authors:  P Knapp
Journal:  Trans Am Ophthalmol Soc       Date:  1969

5.  The surgical treatment of blepharoptosis: a quantitative approach.

Authors:  C Beard
Journal:  Trans Am Ophthalmol Soc       Date:  1966

6.  Vertical transposition of the horizontal rectus muscles for congenital/early onset "acquired" double elevator palsy: a retrospective long term study of 10 consecutive patients.

Authors:  J A Caldeira
Journal:  Binocul Vis Strabismus Q       Date:  2000

7.  Outcome of surgical treatment of monocular elevation deficiency.

Authors:  Saemah Nuzhat Zafar; Nadia Azad; Ayesha Khan
Journal:  J Pak Med Assoc       Date:  2012-04       Impact factor: 0.781

8.  Surgical management of unilateral elevator deficiency associated with horizontal deviation using a modified Knapp's procedure.

Authors:  Subhash Dadeya
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 May-Jun

9.  Surgical management of monocular elevation deficiency combined with inferior rectus restriction.

Authors:  Ahmed Awadein; Dina El-Fayoumi
Journal:  J AAPOS       Date:  2015-07-31       Impact factor: 1.220

10.  Monocular elevation deficiency: a case series of surgical outcome.

Authors:  Mohammad Reza Talebnejad; Gholam Abbas Roustaei; Mohammad Reza Khalili
Journal:  Iran J Med Sci       Date:  2014-03
View more
  1 in total

1.  Clinical features and surgical treatment of double elevator palsy in young children.

Authors:  Wen-Ting Luo; Tong Qiao; Hai-Yun Ye; Si-Hong Li; Quan-Li Chen
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.